{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:30:07Z","timestamp":1784835007366,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002296","name":"Ramathibodi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002296","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research University Grant"},{"name":"Mahidol University Research Grant"},{"name":"National Research University Initiative"},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UT MD Anderson","award":["CCSG Core CA16672"],"award-info":[{"award-number":["CCSG Core CA16672"]}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"crossref","award":["RTA 488-0007"],"award-info":[{"award-number":["RTA 488-0007"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbmt.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T16:03:09Z","timestamp":1406131389000},"page":"2066-2071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification"],"prefix":"10.1016","volume":"20","author":[{"given":"Usanarat","family":"Anurathapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samart","family":"Pakakasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimsiri","family":"Mekjaruskul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongnuch","family":"Sirachainan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duantida","family":"Songdej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ampaiwan","family":"Chuansumrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimlak","family":"Charoenkwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Jetsrisuparb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleebsabai","family":"Sanpakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunchoo","family":"Pongtanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Rujkijyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunotai","family":"Meekaewkunchorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosarin","family":"Sruamsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artit","family":"Ungkanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borje S.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.07.016_bib1","series-title":"Marrow transplantation in thalassemia","first-page":"1412","author":"Lucarelli","year":"2004"},{"key":"10.1016\/j.bbmt.2014.07.016_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(85)91784-2","article-title":"Marrow transplantation for thalassaemia following busulphan and cyclophosphamide","volume":"1","author":"Lucarelli","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2014.07.016_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bbmt.2014.07.016_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","article-title":"A\u00a0new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.016_bib5","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for beta-thalassemia major","volume":"117","author":"Sabloff","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.016_bib6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V80.6.1603.1603","article-title":"Bone marrow transplantation in adult thalassemia","volume":"80","author":"Lucarelli","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.016_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"Sodani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.016_bib8","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.V87.5.2082.2082","article-title":"Marrow transplantation for patients with thalassemia: results in class 3 patients","volume":"87","author":"Lucarelli","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.016_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for haematopoietic stem cell transplantation in patients with thalassemia major","volume":"143","author":"Bernado","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.07.016_bib10","doi-asserted-by":"crossref","first-page":"e61637","DOI":"10.1371\/journal.pone.0061637","article-title":"Improved clinical outcome of high risk thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with treosulfan-based conditioning regimen and peripheral blood stem cell grafts","volume":"8","author":"Mathews","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2014.07.016_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/pbc.24493","article-title":"Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major","volume":"60","author":"Hussein","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2014.07.016_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","article-title":"Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes","volume":"8","author":"Russell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.016_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.016_bib14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbmt.2013.04.023","article-title":"Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: safe approach to disease control","volume":"19","author":"Anurathapan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.016_bib15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ajh.21002","article-title":"Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients","volume":"82","author":"Hongeng","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2014.07.016_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1704361","article-title":"Outcome of transplantation with unrelated donor bone marrow in children with severe thalassemia","volume":"33","author":"Hongeng","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.016_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbmt.2006.02.008","article-title":"Outcome of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia","volume":"12","author":"Hongeng","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.016_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-3046.2008.00953.x","article-title":"Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2009","journal-title":"Pediatr Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911400442X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911400442X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:07Z","timestamp":1761058147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911400442X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S108387911400442X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.016","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}